Ecor1 Capital key facts
- Ecor1 Capital is a hedge fund based in San Francisco, CA with 15 tracked portfolio companies.
- Notable positions include Freenome, Eikon Therapeutics (NAS: EIKN), ReCode Therapeutics.
- The team roster lists 1 person.
- Ecor1 Capital reports $669.0M in regulatory assets under management across 3 private funds, per its SEC Form ADV (2026-03).
Investment focus
Its SEC Form ADV lists $669 million in regulatory assets under management across 3 private funds (Mar 2026).
Ecor1 Capital portfolio at a glance
15 portfolio companies are on record for Ecor1 Capital, including Freenome, Eikon Therapeutics (NAS: EIKN) and ReCode Therapeutics.
13 of the 15 carry a recorded valuation.
Ecor1 Capital team
1 person is on record at Ecor1 Capital. Senior names include Scott Nicholson (Executive). 1 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Ecor1 Capital at the SEC
Form ADV · 2026-03 · CRD 167121- Regulatory AUM
- $669.0M
- Private fund assets
- $3.4B
- Private funds
- 3 · 1 venture, 2 hedge
- Staff
- 22
- Registered office
- SAN FRANCISCO, CA
- SEC status
- Approved
Discloses a disciplinary history on Form ADV. Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as ECOR1 CAPITAL, LLC).
- ·The top 10 names in the book — of 15 recorded positions
- ·Watchlist + alerts for Ecor1 Capital's activity
Portfolio
15 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | ▮ | ▮ | ▮ |
| Eikon Therapeutics (NAS: EIKN) | — | ▮ | ▮ | ▮ |
| ReCode Therapeutics | — | ▮ | ▮ | ▮ |
+ 12 more companies · all 15, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Ecor1 Capital
- What companies does Ecor1 Capital invest in?
- Ecor1 Capital has 15 recorded portfolio companies, including Freenome, Eikon Therapeutics (NAS: EIKN), ReCode Therapeutics.